Lincoln Alternative Strategies LLC - 17 Sep 2025 SCHEDULE 13G Report for Bionano Genomics, Inc. Common Stock, par value $0.0001 per share (BNGO)

Filing Manager
Lincoln Alternative Strategies LLC
Reporting Manager
Lincoln Alternative Strategies LLC
Security
Bionano Genomics, Inc. Common Stock, par value $0.0001 per share
Symbol
BNGO
Shares outstanding
9,686,347 shares
Disclosed Ownership
525,000 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
17 Sep 2025, 16:05:02 UTC
Date of event
17 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Lincoln Alternative Strategies LLC disclosed 5.4% ownership in Bionano Genomics, Inc. Common Stock, par value $0.0001 per share (BNGO) on 17 Sep 2025."

Quick Takeaways

  • Lincoln Alternative Strategies LLC filed SCHEDULE 13G for Bionano Genomics, Inc. Common Stock, par value $0.0001 per share (BNGO).
  • Disclosed ownership: 5.4%.
  • Date of event: 17 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Sep 2025, 16:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lincoln Alternative Strategies LLC 5.4% 525,000 525,000 0 /s/ Stephen Temes Stephen Temes/Managing Member

Sponsored